Subsequent Events (Details Narrative) - USD ($) |
12 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Mar. 27, 2026 |
Feb. 18, 2026 |
Jan. 28, 2026 |
May 27, 2025 |
Jan. 13, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Jan. 22, 2026 |
Jul. 23, 2025 |
Jul. 22, 2025 |
|
| Subsequent Event [Line Items] | ||||||||||
| Common stock, shares authorized | 6,250,000 | 6,250,000 | 50,000,000 | 1,388,888 | ||||||
| Gross proceeds | $ 400,000 | $ 900,000 | ||||||||
| Notes, description | (i) the Maxim agreed to act as lead placement agent on a “best efforts” basis in connection with the Jan 2025 Offering, and (ii) the Company agreed to pay the Maxim an aggregate fee equal to 6.5% of the gross proceeds raised in the Jan 2025 Offering (or 5.0% in the case of certain investors) and warrants to purchase up to | |||||||||
| Common stock exercise price | $ 1,260.00 | |||||||||
| J A G Notes [Member] | ||||||||||
| Subsequent Event [Line Items] | ||||||||||
| Notes, description | (i) the maturity date of the JAG Notes was extended until December 31, 2026, (ii) the Company agreed to repay the JAG Notes in monthly installments of $50,000 starting in April 2026 with a balloon payment at the end of December 2026, (iii) confirmation that if the Company raises more than $3,000,000 after the date of the JAG May 2026 Letter, the Company shall pay ten percent (10%) of any proceeds in excess of $3,000,000 to accelerate repayment of the JAG Notes, (iv) the conversion price of the JAG Notes was set to $1.60, (v) the Company agreed to issue to JAG a new warrant (the “JAG May 2026 Warrant”) to purchase up to 150,000 shares of the Company’s common stock at an exercise price of $1.60 per share, exercisable for five years from the date of issuance, and (vi) the Company agreed to the reset of the conversion and exercise prices of the JAG Notes and JAG May 2026 Warrant, respectively, to equal the price of any future financing based on a share price that is lower than the conversion and exercise prices then in effect. | |||||||||
| Extended maturity date | Dec. 31, 2026 | |||||||||
| Monthly installments | $ 50,000 | |||||||||
| Conversion price | $ 1.60 | |||||||||
| Number of warrants to purchase common stock | 150,000 | |||||||||
| Common stock exercise price | $ 1.60 | |||||||||
| Warrants exercisable term | 5 years | |||||||||
| Subsequent Event [Member] | ||||||||||
| Subsequent Event [Line Items] | ||||||||||
| Common stock, shares authorized | 250,000,000 | |||||||||
| Reverse stock split | 1-for-5 reverse stock split | |||||||||
| Subsequent Event [Member] | Family Beginnings P C [Member] | ||||||||||
| Subsequent Event [Line Items] | ||||||||||
| Purchase price | $ 760,000 | |||||||||
| Payments made in cash | 210,000 | |||||||||
| Holdback funds | 150,000 | |||||||||
| Subsequent Event [Member] | Family Beginnings P C [Member] | Series D Preferred Stock [Member] | ||||||||||
| Subsequent Event [Line Items] | ||||||||||
| Number of shares issued on acquisition | $ 400,000 | |||||||||
| Number of shares issued on acquisition, shares | 400 | |||||||||
| Subsequent Event [Member] | Warrant Inducement Agreement [Member] | ||||||||||
| Subsequent Event [Line Items] | ||||||||||
| Gross proceeds | $ 7,500,000 | |||||||||